A multidimensional proteomic approach to identify hypertrophy-associated proteins

Area of Science:

• Cardiovascular Biology
• Proteomics
• Molecular Cardiology

Background:

• Left ventricular hypertrophy (LVH) is a major precursor to congestive heart failure.
• The precise molecular mechanisms driving cardiac hypertrophy and its progression to failure remain incompletely understood.
• A comprehensive understanding of the protein landscape in LVH is crucial for elucidating these mechanisms.

Purpose of the Study:

• To investigate the proteomic alterations associated with left ventricular hypertrophy (LVH).
• To identify known and novel proteins implicated in the development and progression of pressure-induced cardiac hypertrophy.
• To provide a detailed protein inventory for future research into LVH pathogenesis.

Main Methods:

• Utilized the transverse aortic constriction (TAC) mouse model to induce pressure overload and LVH.
• Employed a multidimensional proteomic approach for comprehensive protein identification and quantification.
• Integrated various proteomic techniques to ensure a robust and thorough analysis.

Main Results:

• Identified 123 differentially expressed proteins in the hypertrophied left ventricle.
• Key identified proteins include LIM proteins, thioredoxin, myoglobin, fatty acid binding protein 3, ASPM, actin, and myosin.
• Discovered several proteins with previously unknown functions in the context of LVH, opening new research avenues.

Conclusions:

• The study provides a significant expansion of the known proteome associated with LVH.
• The identified proteins offer potential targets for understanding and treating heart failure progression.
• The multidimensional proteomic strategy enhances our understanding of the molecular basis of cardiac hypertrophy.